MAZE
Maze Therapeutics Inc.

46
Mkt Cap
$1.28B
Volume
267,875.00
52W High
$31.93
52W Low
$6.71
PE Ratio
-17.29
MAZE Fundamentals
Price
$29.90
Prev Close
$29.12
Open
$29.16
50D MA
$21.61
Beta
1.06
Avg. Volume
845,065.81
EPS (Annual)
$0.0778
P/B
4.87
Rev/Employee
$1.34M
Loading...
Loading...
News
all
press releases
News Placeholder
Maze Therapeutics Stock Just Shot Up 56% Pre-Market Today – Here’s What Happened
The company announced a private placement for over four million shares of common stock at $16.25 apiece, representing a premium of over 1% from the stock’s closing price on Wednesday.
Stocktwits·1mo ago
News Placeholder
Maze Therapeutics receives positive ratings following recent IPO
Investing.com -- Maze Therapeutics Inc (NASDAQ:MAZE) received bullish coverage from multiple analysts, with Guggenheim, JPMorgan, and TD Cowen initiating Buy or Overweight ratings on the company given its potential in genetically targeted therapies.
investing.com·8mo ago

Latest MAZE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.